Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Common Anti-Inflammatory drug could be key to preventing chronic pain after blood clots

NCT ID NCT06440694

Summary

This study is testing if a low daily dose of the anti-inflammatory drug colchicine can prevent a painful, long-term condition called post-thrombotic syndrome (PTS) in people who have just had a major leg blood clot (DVT). 150 adults will take either colchicine or a placebo pill daily for about 6 months while also receiving standard blood thinner treatment. The main goal is to see if this simple add-on treatment reduces the risk of developing chronic leg swelling, pain, and skin changes.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre de recherche du Centre hospitalier de l'Université de Montréal

    RECRUITING

    Montreal, Quebec, H2X 0A9, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The Ottawa Hospital General Campus

    RECRUITING

    Ottawa, Ontario, K1H 8L6, Canada

    Contact

    Contact Email: •••••@•••••

  • The Sir Mortimer B. Davis Jewish General Hospital

    NOT_YET_RECRUITING

    Montreal, Quebec, H3T 1E2, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.